Cori Clinical raises $4m: Evertrace spotted Jorn Jansen Schoonhoven 720 days earlier

Cori Clinical has raised $4m in seed funding, led by Breega. The company offers an AI workspace that helps teams design clinical trials and cut delays.

Evertrace spotted Jorn Jansen Schoonhoven, co-founder of Cori Clinical, 720 days before the funding announcement.

Before the round

On 17 October 2024, Evertrace detected a stealth signal for Jorn Jansen Schoonhoven. Jorn was in stealth, working on something new. That was 720 days before Cori Clinical's funding announcement.

Jorn Jansen Schoonhoven founded Cori Clinical with Patricio Fernández.

What they’re building

Designing a clinical trial means bringing together past trial data, registries and regulatory guidance. Cori Clinical's AI workspace combines an organisation's own knowledge from past trials with trial registries, regulatory guidance and agency data from the FDA, MHRA and EMA.

It turns an initial trial brief into a full protocol, a submission package and operational plans, a living blueprint for each trial.

The round

Breega led the $4m seed round, with Enzo, Heartfelt, Together Ventures and Bynd. Cori Clinical will use the funding for product development, more delivery capacity, team growth, deeper regulatory and clinical intelligence, and commercial relationships with CROs and pharma companies.

Read the funding coverage →

Find your next investment before the round. Explore Evertrace →